Skip to content
Book a Free Consultation
An older person's hands resting on a white surface

Specialty billing Rheumatology

Rheumatology Billing and Coding Services

Rheumatology billing requires specialized expertise because biologic infusions combine high-cost drugs, complex coding, and strict payer requirements. Errors in J-codes, drug units, prior authorization, or JW/JZ modifiers can quickly lead to denials and lost revenue. MedixCode provides specialized rheumatology medical billing and RCM support, helping practices get infusion billing, buy-and-bill reimbursement, biologics billing and payer compliance right.

Book a Free Consultation Our Medical Billing Services
  • HIPAA compliant
  • AAPC/CPC Certified Coders and Billers
  • Works inside your existing EHR/PM system (Epic, athenahealth, eClinicalWorks, NextGen, Tebra, AdvancedMD)
  • You keep ownership of your data

Rheumatology focus

  • JW/JZ Modifier Compliance
  • 96365 Infusion Coding
  • PA Biologics Auth

Drug Billing Precision

J-Codes, Units, and the JW/JZ Modifier Trap

Accurate rheumatology infusion billing depends on getting the drug units right before the claim is ever submitted. JW and JZ requirements depend on the drug's packaging, payment status, payer, site of service, and date of service. Here's what we look for:

J-code, unit and modifier checks
Billing ElementCorrect ApproachCommon Error
J-code & HCPCSReport the correct HCPCS Level II J-code for the biologic administered.Using an outdated or incorrect J-code.
Units vs. VialsBill the number of HCPCS units based on the administered dose—not the number of vials opened.Confusing vial count with billable units.
JW ModifierReport the discarded amount on its own line with JW when part of a single-dose container is discarded (Medicare Part B separately payable drugs).Omitting JW or reporting waste incorrectly.
JZ ModifierAppend JZ when no drug is discarded from a single-dose container.Leaving off JZ, which Medicare has required since July 1, 2023 when nothing is discarded from a single-dose container.
NDC ReportingReport the correct NDC and quantity when required by the payer.Missing or mismatched NDC information.

Infusion Hierarchy

Infusion Coding: Initial, Sequential, and Concurrent Hours

Our AAPC/CPC Certified Coders and Billers review infusion records before submission to prevent bundling errors, reduce denials, and support correct reimbursement.

Infusion coding hierarchy
Infusion ScenarioCPT CodeBilling TipCommon Error
Initial IV infusion (first hour)96365Report the primary infusion service with documented start and stop times.Billing without complete time documentation.
Each additional hour96366Use only after the initial hour when medically necessary and time requirements are met.Billing extra hours that don't meet CPT time thresholds.
Sequential infusion of a different drug96367Report when a new medication is administered after the initial infusion.Incorrectly billing as an additional hour instead of a sequential infusion.
Concurrent infusion96368Use when a separate drug is infused simultaneously through the same IV access.Reporting concurrent infusions as separate initial services.

Revenue Protection

Prior Authorization for Biologics Is the Most Revenue-Protective Activity in a Rheumatology Practice

As part of our rheumatology billing services and rheumatology revenue cycle management, we help practices spend less time chasing approvals and more time delivering patient care with this proactive workflow:

  1. 01

    Benefit Verification: To determine whether the biologic is covered under the medical benefit or pharmacy benefit.

  2. 02

    Complete Prior Authorization Submission: With clinical documentation to minimize payer delays.

  3. 03

    Step Therapy Management: By tracking payer requirements and preparing medical necessity documentation for exception requests.

  4. 04

    Renewal Tracking: We track expiration dates and start renewals ahead of time, so approvals are renewed before therapy is due.

  5. 05

    Appeals Management: For denied or delayed authorizations, with continuous payer follow-up until a final determination is received.

Gloved hands examining a patient's hand and wrist

Reimbursement Model

Buy-and-Bill vs. Specialty Pharmacy: Which Model Is Costing Your Practice More?

Choosing the right reimbursement model has a direct impact on your profitability. Successful rheumatology billing services help practices evaluate whether buy-and-bill reimbursement or specialty pharmacy billing delivers the best financial outcome based on payer contracts, drug costs, and reimbursement policies.

Buy-and-Bill

  • Practice purchases and stocks the biologic, then bills the payer under the medical benefit.
  • Generates revenue from both drug reimbursement and administration services.
  • Greater control over scheduling, inventory, and patient treatment.
  • Requires accurate J-codes, drug units, and strong rheumatology medical billing processes.
  • Best suited for practices with efficient biologics billing services and reimbursement monitoring.

Specialty Pharmacy

  • Medication is dispensed by a specialty pharmacy and shipped for administration.
  • Administration revenue remains, but drug reimbursement is typically removed.
  • Treatment delays can occur due to shipping issues or coordination failures.
  • Requires close coordination with the specialty pharmacy and payer requirements.
  • Increasingly required by some payers through white bagging or brown bagging policies.

MedixCode helps providers evaluate payer requirements, monitor reimbursement trends, and track reimbursement on biologic treatments.

2026 update

The first Medicare negotiated drug prices took effect January 1, 2026 under the Medicare Drug Price Negotiation Program. They include Enbrel and Stelara and apply to Medicare Part D (pharmacy) coverage, not to drugs you buy and bill under Part B. For patients on these drugs, check whether pharmacy-benefit costs have changed.

Source: CMS fact sheet, negotiated prices for initial price applicability year 2026.

End-to-End Workflow

Our Rheumatology Billing Process

Our rheumatology billing services are built to protect reimbursement at every stage of the revenue cycle. Our end-to-end billing workflow includes:

How Pricing Works

You pay a share of net collections, without a setup fee or monthly minimum, and we confirm the rate in writing once we know your infusion volume and payer mix. See how pricing works

Book a Free Consultation
  1. 01

    Charge Capture

    We capture infusion services, biologic administrations, evaluation and management (E/M) visits, and all supporting documentation to ensure nothing billable is missed.

  2. 02

    Coding Validation

    Our team reviews J-codes, HCPCS, CPT, ICD-10 diagnoses, drug units, modifiers, and NDC reporting to support accurate rheumatology medical billing.

  3. 03

    NCCI & LCD Claim Scrubbing

    Claims are checked against NCCI edits, applicable LCD policies, and payer-specific billing rules before submission to reduce preventable denials.

  4. 04

    Drug Reconciliation

    We reconcile administered doses against purchased inventory, verify units vs. vials, and confirm appropriate JW/JZ modifier usage for compliant biologics billing services.

  5. 05

    Electronic Claim Submission

    Clean claims are submitted promptly with continuous tracking to identify payer rejections or processing delays.

  6. 06

    Denial Management & Payment Recovery

    If a claim is denied or underpaid, our team investigates the root cause, files timely appeals, and follows through until the reimbursement issue is resolved, keeping your rheumatology revenue cycle management on track.

Clinicians reviewing an X-ray of a hand on a laptop

Onboarding

Transition to MedixCode

Switching your rheumatology billing services shouldn't disrupt patient care or cash flow. We set the start date with you after reviewing your systems, data access and the payers you bill for biologics. Then we map out who works each open drug and infusion claim during the switch, and you'll get reporting by payer, provider, location and CPT.

Book a Free Consultation

Keep exploring

Related Services and Specialties

Want to compare costs first? See how pricing works

Book a Free Consultation

Related Services

Related Specialties

We can also bill for cardiology, orthopedics, OB/GYN, neurology and psychiatry. Not on the list? Ask us.

FAQ

FAQs

Answers on JW/JZ, rituximab units, authorization renewals, buy-and-bill, appeals and drug billing. More questions? See our FAQ

Q01 What is the difference between the JW and JZ modifiers on biologic claims?

JW reports the amount of a drug discarded from a single-dose container. JZ shows that nothing was discarded. Medicare requires one or the other on separately payable Part B drugs from single-dose containers.

Q02 How do you calculate units for rituximab infusions?

Units come from the HCPCS code descriptor, not the number of vials. Rituximab (J9312) is billed per 10 mg, so a 750 mg dose is 75 units. Biosimilar rituximab products have their own codes.

Q03 Do you handle prior authorization renewals for biologics?

Yes. We track authorization expiration dates, start renewals before they lapse, manage step therapy requirements and handle payer appeals to help prevent treatment interruptions and claim denials.

Q04 Can you bill both the drug and the infusion administration together?

Yes, when payer rules allow. Under buy-and-bill, the practice bills the drug with its HCPCS code and the administration with the CPT infusion codes, with the documentation each requires.

Q05 What happens if we bill a wasted single-dose vial without the JW modifier?

Payment for the discarded amount may be denied and the claim may need correction. If nothing was discarded, report JZ instead, as Medicare has required for single-dose container drugs since July 1, 2023.

Q06 Is buy-and-bill more profitable than specialty pharmacy?

It depends on your payer contracts, drug costs and reimbursement. Buy-and-bill lets you bill for both the drug and its administration, but some commercial payers require white bagging or specialty pharmacy distribution, so we look at it payer by payer.

Q07 How do you appeal a denied biologic claim from a commercial payer?

We review the denial reason, check coding, drug units, modifiers, prior authorization and supporting documentation, then submit a payer-specific appeal and follow up until it's resolved or appeal options are exhausted.

Q08 Do you publish a clean claim rate for rheumatology practices?

No. It depends on documentation and the state of your current billing. We check coding, payer edits and drug units before submission, and in the consultation we'll look at your own infusion and biologic claims with you.

Q09 Is drug billing part of your rheumatology billing service?

Yes. Biologics billing, infusion coding, J-code validation, drug unit reconciliation, modifier review and denial management are part of our rheumatology billing work. Your rate is a percentage of net collections, confirmed in writing.

Free Consultation · No Obligation

Protect Your Biologics Revenue

Book a free consultation. We'll review your J-code accuracy, JW/JZ compliance, infusion coding, and prior authorization workflow to show you where revenue is leaking.

Book a Free Consultation Call +1 (307) 443-4766

Prefer email? Send biologic billing questions to info@medixcode.com.

Close-up of an older person's hands with rings resting in their lap